以岭药业(002603.SZ)：中药新药“芪龙定喘片”药物临床试验申请获得受理

Group 1 - The core point of the article is that Yiling Pharmaceutical (002603.SZ) has received the Acceptance Notification from the National Medical Products Administration for its drug Qilong Dingchuan Tablets, which is intended for the treatment of chronic obstructive pulmonary disease (COPD) [1] Group 2 - The proposed indications for Qilong Dingchuan Tablets include invigorating qi, promoting blood circulation, resolving phlegm, stopping cough, and relieving asthma [1] - The drug is specifically aimed at patients with stable COPD characterized by symptoms such as shortness of breath, cough, and fatigue, among others [1]